Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm
- PMID: 20572907
- DOI: 10.1111/j.1552-6569.2010.00502.x
Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm
Abstract
Background and purpose: Features of tumefactive demyelinating lesion (TDL) on magnetic resonance imaging (MRI) can facilitate the differential diagnosis of TDL and neoplastic lesions, but vary considerably among patients. The larger TDL grows, the more difficult it becomes to differentiate TDL from neoplastic lesions. The purpose of this study was to elucidate typical MRI features in 12 patients with large TDL (>30 mm in diameter).
Methods: We identified 12 patients with large TDL (six men, six women; age range 17-64 years, median age 27 years) and studied the clinical histories and the results of laboratory and various radiological studies in these patients. All cases of clinically definite multiple sclerosis were diagnosed in accordance with McDonald's revised criteria.
Results: Common MRI features of large TDLs included variable degrees of mass effect (71%) and edema (100%), a T2 hypointense rim (79%), venular enhancement (57%), and peripheral restriction on diffusion-weighted images (50%). Ring enhancement (38%), open-ring enhancement (31%), or decreased N-acetylaspartate ratios on magnetic resonance spectroscopy (22%) were less frequently observed. Brain angiography demonstrated venous dilatations on and around the TDL.
Conclusions: The diagnosis of large TDL is challenging. Our findings suggest that multiple venous dilatations on and around TDLs on angiography can facilitate diagnosis.
Copyright © 2010 by the American Society of Neuroimaging.
Similar articles
-
Conventional and advanced magnetic resonance imaging in tumefactive demyelination.Acta Radiol. 2011 Dec 1;52(10):1159-68. doi: 10.1258/ar.2011.110007. Epub 2011 Oct 24. Acta Radiol. 2011. PMID: 22025739
-
Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.Turk Neurosurg. 2013;23(6):728-35. doi: 10.5137/1019-5149.JTN.7690-12.3. Turk Neurosurg. 2013. PMID: 24310455
-
Uncovering and characterizing multiple sclerosis lesions: the aid of fluid-attenuated inversion recovery images in the presence of gadolinium contrast agent.J Neuroimaging. 2009 Jul;19(3):201-4. doi: 10.1111/j.1552-6569.2008.00350.x. Epub 2009 Jan 29. J Neuroimaging. 2009. PMID: 19187471 No abstract available.
-
Tumefactive demyelinating lesions.Neuroradiology. 1996 Aug;38(6):560-5. doi: 10.1007/BF00626098. Neuroradiology. 1996. PMID: 8880719 Review.
-
[Neuroimaging in multiple sclerosis].Rev Neurol. 2001 Feb 1-15;32(3):283-5. Rev Neurol. 2001. PMID: 11310287 Review. Spanish.
Cited by
-
Neuroimaging of tumefactive multiple sclerosis with atypical features.Radiol Case Rep. 2015 Dec 7;7(4):752. doi: 10.2484/rcr.v7i4.752. eCollection 2012. Radiol Case Rep. 2015. PMID: 27330599 Free PMC article.
-
Tumefactive multiple sclerosis in Taiwan.PLoS One. 2013 Jul 18;8(7):e69919. doi: 10.1371/journal.pone.0069919. Print 2013. PLoS One. 2013. PMID: 23875010 Free PMC article.
-
Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.J Neurol. 2013 Aug;260(8):2016-22. doi: 10.1007/s00415-013-6918-y. Epub 2013 Apr 26. J Neurol. 2013. PMID: 23620065
-
MRI Findings in Tumefactive Demyelinating Lesions: A Systematic Review and Meta-Analysis.AJNR Am J Neuroradiol. 2018 Sep;39(9):1643-1649. doi: 10.3174/ajnr.A5775. Epub 2018 Aug 16. AJNR Am J Neuroradiol. 2018. PMID: 30115676 Free PMC article.
-
Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System.Chin Med J (Engl). 2017 Aug 5;130(15):1838-1850. doi: 10.4103/0366-6999.211547. Chin Med J (Engl). 2017. PMID: 28748858 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical